HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer
María González‐Cao(Instituto Oncológico Dr. Rosell), Rafael Rosell(Instituto Oncológico Dr. Rosell)
Cited by 5
Related Papers
Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer
|Nature Communications|2017|182
Liquid Biopsy in Non-Small Cell Lung Cancer
|Frontiers in Medicine|2016|66
Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC)
|Oncotarget|2017|49
Hsp90 inhibitors enhance the antitumoral effect of osimertinib in parental and osimertinib-resistant non-small cell lung cancer cell lines
|Translational Lung Cancer Research|2019|17